Transformations in cannabis - from federal rescheduling to European regulatory shifts

This week's stories:The U.S Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be reclassified from Schedule I to Schedule IIINew York has seen its cannabis licensing process draw to a complete halt after a temporary injunction was implemented on New York’s Conditional Adult-Use Retail Dispensary (CAURD) scheme.Canadian cannabis companies are increasingly turning to the international medical cannabis market, seeing exports increase by 50% last year.The report we mention in the episode - Pharmaceutical Cannabis Report: 3rd EditionAre you following the podcast yet? If not, why not? Correct this at once, here -> Follow 😉Check out all the main headlines on our website at businessofcannabis.comBusiness of Cannabis: New York | U.S. Cannabis Conference (cannabisnewyork.live)Business of Cannabis: NYC SessionsCannabis Europa Tweet us and let us know your thoughts on today's episode, here.Email us about our stories or to talk sponsorship of our events, here.Missed the previous episode? You can catch up with it here.  About Cannabis Daily.Cannabis Daily is a cannabis news and interview program from Business of Cannabis. We highlight the companies, brands, people and trends driving the cannabis industry.Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events.Visit Business of Cannabis online:http://businessofcannabis.comTwitter: https://twitter.com/bofc_mediaLinkedIn: https://www.linkedin.com/company/businessofcannabisInstagram: https://instagram.com/businessofcannabisFacebook: https://www.facebook.com/bofcmediaSpotify: http://bofc.me/spotifyApple: http://bofc.me/applepodPodcasts Online: https://bofc.me/bofclive